Co-encapsulated resveratrol and paclitaxel in liposomes coating with RGDfC peptide for drug resistance reversal in renal cell carcinoma
This dual-targeted codelivery system represents a promising strategy for overcoming MDR in advanced renal carcinoma.
Authors
- Guang Jin Zhu (ORCID: https://orcid.org/0009-0001-4548-6222)
- Jianqiang Bian
- Yujie Wang (ORCID: https://orcid.org/0000-0001-5830-2341)
- Chao Wang (ORCID: https://orcid.org/0000-0002-6251-7908)
- Liang Yang (ORCID: https://orcid.org/0000-0003-0632-7568)
Institutions
- Tianjin Hospital (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1093/jpp/rgaf104
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00